90
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Comparative study of treatment options and construction nomograms to predict survival for early-stage esophageal cancer: a population-based study

, , & ORCID Icon
Pages 635-646 | Received 17 Jan 2021, Accepted 27 Mar 2021, Published online: 19 Apr 2021

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.
  • Uhlenhopp DJ, Then EO, Sunkara T, et al. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010–1021.
  • Liu QX, Qiu Y, Deng XF, et al. Comparison of outcomes following end-to-end hand-sewn and mechanical oesophagogastric anastomosis after oesophagectomy for carcinoma: a prospective randomized controlled trial. Eur J Cardiothorac Surg. 2015;47(3):e118–e123.
  • Semenkovich TR, Hudson JL, Subramanian M, et al. Trends in Treatment of T1N0 Esophageal Cancer. Ann Surg. 2019;270(3):434–443.
  • Wani S, Drahos J, Cook MB, et al. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study. Gastrointest Endosc. 2014;79(2):224–232 e1.
  • Iyer R, Wilkinson N, Demmy T, et al. Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy. Ann Surg Oncol. 2004;11(7):665–673.
  • Zhu C, Wang S, You Y, et al. Risk factors for esophageal fistula in esophageal cancer patients treated with radiotherapy: a systematic review and meta-analysis. Oncol Res Treat. 2020;43(1-2):34–41.
  • van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–2084.
  • Shapiro J, van Lanschot JJ, Hulshof MC, et al. Effectiveness of neoadjuvant chemoradiotherapy for early-stage esophageal cancer. J Clin Oncol. 2015;33(3):288–289.
  • Cummings LC, Kou TD, Schluchter MD, et al. Outcomes after endoscopic versus surgical therapy for early esophageal cancers in an older population. Gastrointest Endosc. 2016;84(2):232–240 e1.
  • Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565–574.
  • Robertson K. Bailey and Love’s short practice of surgery. BMJ. 2008;337:a2601.
  • Qi ZP, Chen T, Li B, et al. Endoscopic submucosal dissection for early esophageal cancer in elderly patients with relative indications for endoscopic treatment. Endoscopy. 2018;50(9):839–845.
  • Bustamante FA, Hourneaux D, Bernardo W, et al. SURGERY VERSUS ENDOSCOPIC THERAPIES FOR EARLY CANCER AND HIGH-GRADE DYSPLASIA IN THE ESOPHAGUS: a systematic review. Arq Gastroenterol. 2016;53(1):10–19.
  • Zeng Y, Liang W, Liu J, et al. Endoscopic treatment versus esophagectomy for early-stage esophageal cancer: a population-based study using propensity score matching. J Gastrointest Surg. 2017;21(12):1977–1983.
  • Liu L, Hofstetter WL, Rashid A, et al. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol. 2005;29(8):1079–1085.
  • Leers JM, DeMeester SR, Oezcelik A, et al. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Ann Surg. 2011;253(2):271–278.
  • Manner H, Pech O, Heldmann Y, et al. Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol. 2013;11(6):630–635.
  • Tian J, Prasad GA, Lutzke LS, et al. Outcomes of T1b esophageal adenocarcinoma patients. Gastrointest Endosc. 2011;74(6):1201–1206.
  • Minashi K, Nihei K, Mizusawa J, et al. Efficacy of endoscopic resection and selective chemoradiotherapy for stage I esophageal squamous cell carcinoma. Gastroenterology. 2019;157(2):382–390 e3.
  • Ishihara R, Yamamoto S, Iishi H, et al. Factors predictive of tumor recurrence and survival after initial complete response of esophageal squamous cell carcinoma to definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2010;76(1):123–129.
  • Conroy T, Yataghene Y, Etienne PL, et al. Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer. Br J Cancer. 2010;103(9):1349–1355.
  • Qin J, Peng Y, Chen W, et al. Comparative study of esophagectomy, endoscopic therapy, and radiotherapy for cT1N0M0 esophageal cancer in elderly patients: a SEER database analysis. Thorac Cancer. 2019;10(7):1511–1520.
  • Nakamura R, Omori T, Takeuchi H, et al. Salvage endoscopic resection as a treatment for locoregional failure or recurrence following chemoradiotherapy or radiotherapy for esophageal cancer. Oncol Lett. 2016;11(6):3631–3636.
  • Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12(7):681–692.
  • Mariette C, Dahan L, Mornex F, et al. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. J Clin Oncol. 2014;32(23):2416–2422.
  • Zhang QW, Lin XL, Zhang CH, et al. The influence of marital status on the survival of patients with esophageal cancer: a population-based, propensity-matched study. Oncotarget. 2017;8(37):62261–62273.
  • Zhu ZJ, Hu Y, Zhao YF, et al. Early recurrence and death after esophagectomy in patients with esophageal squamous cell carcinoma. Ann Thorac Surg. 2011;91(5):1502–1508.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.